Bandingkan Harga & Kinerja Pudjiadi & Sons Tbk. (PNSE) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Pudjiadi & Sons Tbk. dan Organon Pharma Indonesia Tbk.: Pudjiadi & Sons Tbk. diperdagangkan di Rp498 (kapitalisasi pasar 398,91 M, volume 24 jam 4,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pudjiadi & Sons Tbk. jauh lebih besar — sekitar 3,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PNSE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 398,91 M | 104,4 M |
Volume | 4,1 rb | — |
Lot | 41 | — |
Perputaran | 2,01 jt | — |
Harga Rata-rata | 490,93 | — |
Nilai Transaksi | 2,01 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Pudjiadi & Sons Tbk.
PT Pudjiadi and Sons Tbk was established based on Notarial Deed No. 34 dated December 17, 1970 of Ridwan Suselo, s.h., notaris in Jakarta. Hotel business with all the facilities and infrastructures, such as , accommodation, office, shopping mall, apartment, recreation place and entertainment in the location of hotel. The Company is the owner of Jayakarta Hotel, a four star hotel.
Selengkapnya di halaman PNSE →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
